Subhas S Karki

Title: Subhas S Karki: Innovator in Anticancer Research

Introduction

Subhas S Karki is a notable inventor based in El Paso, TX (US). He has made significant contributions to the field of anticancer research through his innovative work on pyrazole derivatives. His research focuses on discovering compounds with cytotoxic activity against cancer cell lines, which has the potential to lead to new cancer treatments.

Latest Patents

Karki holds a patent for "Pyrazole derivatives with anticancer activity." This patent describes the use of a differential nuclear staining (DNS) assay to identify compounds that exhibit cytotoxic effects against the CEM cell line, known for its sensitivity to various anticancer agents. The compounds synthesized are based on a pyrazole backbone structure. Among the newly synthesized compounds, SSK-3 has shown promising results in inducing apoptosis in cancer cell lines through mechanisms involving phosphatidylserine membrane exposure and activation of caspase 3.

Career Highlights

Throughout his career, Subhas S Karki has worked with prestigious institutions such as the University of Texas System and the University of California. His research has contributed to the understanding of anticancer compounds and their mechanisms of action.

Collaborations

Karki has collaborated with notable colleagues, including Renato J Aguilera and Sujeet Kumar, to advance his research in the field of cancer therapeutics.

Conclusion

Subhas S Karki's innovative work in developing pyrazole derivatives for anticancer applications highlights his commitment to advancing medical research. His contributions may pave the way for new treatments in the fight against cancer.